EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pre-Transplant Prognostic Nutritional Index Independently Predicts Progression-Free Survival After Autologous Stem Cell Transplantation in Lymphoma

Hüseyin Atacan iD, Volkan Aslan iD, Alper Topal iD, Nurlan Mammadzada iD, Gizem Yıldırım, Gökçe Gül Güneysu, Berkan Karadurmuş iD, Esmanur Kaplan Tüzün, Ömer Faruk Kuzu iD, Efe Cem Erdat iD, Musa Barış Aykan iD, İsmail Ertürk und 1 weitere

Journal of Clinical Medicine · 06.05.2026 · 15 (9) · 3549

DOI: 10.3390/jcm15093549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.05.2026. Verfasst von Hüseyin Atacan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autologous stem cell transplantation (ASCT) is a standard treatment for relapsed or high-risk lymphoma. While disease-related factors are well-known, the impact of host-related factors like nutritional status remains less defined. We aimed to evaluate the prognostic value of the prognostic nutritional index (PNI) and other factors in lymphoma patients undergoing ASCT.

Methods

We conducted a single-center retrospective cohort study including adult patients with Hodgkin and non-Hodgkin lymphoma who underwent ASCT between January 2015 and December 2023. Pre-transplant clinical, laboratory, and transplant-related variables were analyzed. The prognostic nutritional index (PNI) was calculated using serum albumin and absolute lymphocyte count and dichotomized according to the cohort median. Progression-free survival (PFS) and overall survival (OS) were evaluated using Kaplan–Meier and Cox regression analyses. We conducted a retrospective single-center cohort study including adult patients with Hodgkin and non-Hodgkin lymphoma who underwent ASCT between January 2015 and December 2023.

Results

A total of 43 patients were included. Median age was 38 years, and 72.1% were male. Patients transplanted in complete remission (CR) had significantly longer PFS compared with those transplanted in partial remission (PR) (log-rank p = 0.022). Patients with higher pre-ASCT PNI demonstrated significantly improved PFS (median 45 vs. 7 months; log-rank p = 0.021). In multivariable Cox regression analysis, both higher PNI (HR 0.39; 95% CI 0.16–0.97; p = 0.043) and complete remission prior to ASCT (HR 0.41; 95% CI 0.17–0.98; p = 0.046) remained independently associated with improved PFS. Higher infused CD34+ (hematopoietic stem cell) dose was associated with shorter hospitalization but showed no statistically significant association with engraftment kinetics or survival. No variable was independently associated with OS, likely due to the limited number of death events.

Conclusions

Pre-transplant prognostic nutritional index and disease response independently predict progression-free survival after ASCT in lymphoma. These findings highlight the complementary role of host-related and disease-related factors in transplant outcomes and suggest that PNI may serve as a practical tool for pre-transplant risk stratification and patient optimization. Given the small sample size and limited number of events, these findings should be interpreted with caution.

Schlagwörter

Stichwörter der Autor:innen

CD34+ cell doseautologous stem cell transplantationlymphomapre-transplant responseprognostic nutritional indexprogression-free survival

Autor:innen und Institutionen

  • Department of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye.
  • Department of Medical Oncology, Tokat Gaziosmanpaşa University, Tokat 60150, Türkiye.
  • Department of Medical Oncology, Çankırı State Hospital, Çankırı 18100, Türkiye.

ORCID-Profile: Hüseyin Atacan, Volkan Aslan, Alper Topal, Nurlan Mammadzada, Berkan Karadurmuş, Ömer Faruk Kuzu, Efe Cem Erdat, Musa Barış Aykan

Zitieren

APA

Atacan, H., Aslan, V., Topal, A., Mammadzada, N., Yıldırım, G., Güneysu, G. G., Karadurmuş, B., Kaplan Tüzün, E., Kuzu, Ö. F., Erdat, E. C., Aykan, M. B., Ertürk, İ., & Karadurmuş, N. (2026). Pre-Transplant Prognostic Nutritional Index Independently Predicts Progression-Free Survival After Autologous Stem Cell Transplantation in Lymphoma. Journal of Clinical Medicine, 15(9), 3549. https://doi.org/10.3390/jcm15093549

Vancouver

Atacan H, Aslan V, Topal A, Mammadzada N, Yıldırım G, Güneysu GG, et al. Pre-Transplant Prognostic Nutritional Index Independently Predicts Progression-Free Survival After Autologous Stem Cell Transplantation in Lymphoma. Journal of Clinical Medicine. 2026;15(9):3549. doi:10.3390/jcm15093549

BibTeX
@article{Atacan2026,
  author = {Atacan, Hüseyin and Aslan, Volkan and Topal, Alper and Mammadzada, Nurlan and Yıldırım, Gizem and Güneysu, Gökçe Gül and Karadurmuş, Berkan and Kaplan Tüzün, Esmanur and Kuzu, Ömer Faruk and Erdat, Efe Cem and Aykan, Musa Barış and Ertürk, İsmail and Karadurmuş, Nuri},
  title = {Pre-Transplant Prognostic Nutritional Index Independently Predicts Progression-Free Survival After Autologous Stem Cell Transplantation in Lymphoma},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {9},
  pages = {3549},
  doi = {10.3390/jcm15093549}
}
Kostenlos starten →